Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is the active ingredient in both Wegovy and Ozempic
One of the advantages of XERF is that it is designed to be a non-surgical treatment with minimal disruption to daily life
These movements create space between vertebrae and ease disc pressure
For persistent nausea or constipation, your provider may suggest antiemetic or laxative support
Regular physical activity remains one of the most effective non-pharmacological methods to boost GLP-1
While Saxenda (liraglutide) was the first GLP-1 agonist approved for weight loss, Wegovy (semaglutide) became the first once-weekly GLP-1 medication to receive FDA approval for weight management
